Medgenics Mourns the Loss of Board Member Gary Brukardt
August 28 2012 - 9:00AM
Business Wire
Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG), the
developer of Biopump™, a novel technology for the sustained
production and delivery of therapeutic proteins in patients using
their own tissue, announces the passing of Director Gary Brukardt
on Tuesday, August 21, 2012. Mr. Brukardt, age 66, had served on
the Company’s Board of Directors since 2006 and was a member of the
Audit Committee and the Nominating and Corporate Governance
Committee.
"We are deeply saddened by the sudden and untimely passing of
Gary Brukardt, our esteemed colleague and friend. Gary was
dedicated to the success of Medgenics and his insight, energy and
judgment as a Director made him an integral part of our leadership
team,” stated Andrew L. Pearlman, Ph.D., President and Chief
Executive Officer of Medgenics. “On behalf of the Board of
Directors and all of Medgenics, we offer our condolences to his
family. Our thoughts and sympathies are with them at this difficult
time."
Mr. Brukardt had more than 30 years of experience in the
healthcare industry. He was a founder of SpecialtyCare and served
as its Chairman and CEO until his passing. Under his leadership
SpecialtyCare became the premier provider of outsourced clinical
services, supporting 322,000 surgical procedures annually at more
than 760 hospitals.
Previously he was EVP and COO of Renal Care Group, after which
time he served as its President and CEO. Renal Care Group provided
dialysis services to more than 32,500 patients at more than 450
outpatient dialysis facilities. Mr. Brukardt led Renal Care Group’s
$3.5 billion acquisition by Fresenius Medical Care in March 2006,
which resulted in the creation of the world’s largest integrated
provider of dialysis services.
Earlier in his career he was EVP of Baptist Health Care
Affiliates while also serving as Chairman of HealthNet Management,
Inc., a managed care services company.
Mr. Brukardt was raised in De Pere, Wisconsin and, following
service in the U.S. Army, graduated from the University of
Wisconsin Oshkosh with a Bachelor of Arts in International Studies.
He received a Masters of Business Administration in International
Management from Thunderbird School of Global Management in
Glendale, Arizona.
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jul 2023 to Jul 2024